The Contribution of Childhood ADHD, Conduct Problems, and Stimulant Treatment to Adolescent and Adult Tobacco and Psychoactive Substance Abuse
The investigation capitalizes on a 28-year prospective longitudinal study of hyperactive (ADHD) and age mate control participants identified from among 5212 elementary school children in randomly sampled classrooms from grades kindergarten through 5. The participants were followed from childhood through adolescence and interviewed 3 times in adulthood to document their life histories and the ages and use of licit and illicit substances over the developmental course. The Children's Attention and Adjustment survey provided parent and teacher rating scales of the cardinal symptoms of ADHD—inattention, impulsivity and hyperactivity—as well as ratings of conduct problems. The ratings were available at baseline, making possible the classification of all of the participants by research diagnostic proxies for DSM-IV ADHD. The substance use data included the age of initiation into tobacco, alcohol, marijuana, cocaine, and amphetamines, daily smoking and lifetime use of the substances, and DSM-III-R diagnoses of psychoactive substance use disorder at an average age of 26. Survival analysis of the age of regular smoking showed that the severity of ADHD symptoms lowered the survival rate for regular smoking. Severity of conduct problems also lowered the survival rate. Stimulant treatment affected lower survival rates, and when participants were classified by the age when stimulant treatment stopped, a protective effect was evident: Regular smoking did not begin until stimulant treatment ended. But the protective effect was short-lived. Those who had been treated with stimulants were significantly more likely to be daily smokers in adulthood. Chi-square analysis of ADHD, problem behavior and stimulant treatment showed a significant association between ADHD and between stimulant treatment and DSM-III-R diagnoses of tobacco dependence, and cocaine dependence. ADHD was also significantly associated with amphetamine dependence. Childhood conduct problems were significantly associated only with tobacco dependence. ADHD and stimulant treatment were each significantly associated with daily smoking in adulthood. Stimulant treatment was associated as well with lifetime use of amphetamine, and conduct problems only with the lifetime use of marijuana. Logistic regression was used to model the prediction of psychoactive substance dependence and lifetime use. Being initiated into tobacco by age 13 increased the odds of dependence on all of the substances in the investigation. Severity of ADHD increased the odds of dependence on tobacco, cocaine, amphetamine, and cocaine/amphetamine when the contribution of other variables in the analysis was accounted for. Stimulant treatment increased the odds of dependence on tobacco, cocaine, and cocaine/amphetamine. The logistic regressions for lifetime use as the dependent variable showed that being initiated into tobacco by age 13 increased the risk for lifetime use of all of the substances. Having been treated with stimulants increased the odds of adult daily smoking and lifetime use of amphetamine and cocaine/amphetamines. ADHD and problem behavior did not increase the odds of either daily smoking or lifetime use of any of the substances. The study supported hypotheses that tobacco serves as a gateway substance for dependence and lifetime use of all of the substances investigated. Self-medication, problem behavior, and sensitization hypotheses were discussed as possible explanations for the findings.
No Reference information available - sign in for access.
No Citation information available - sign in for access.
No Supplementary Data.
No Article Media
Document Type: Research Article
Publication date: 01 September 2005
More about this publication?
- Ethical Human Psychology and Psychiatry is no longer available to subscribers on Ingenta Connect. Please go to http://connect.springerpub.com/content/sgrehpp to access your online subscription to Ethical Human Psychology and Psychiatry.